1.
EANM/EARL harmonization strategies in PET quantification: From daily practice to multicentre oncological studies
by Aide, Nicolas
European journal of nuclear medicine and molecular imaging, 2017-08, Vol.44 (S1), p.17-31
2.
FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
by Aide, Nicolas
European journal of nuclear medicine and molecular imaging, 2018-10-05, Vol.46 (1), p.238-250
3.
Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma
by Aide, Nicolas
European journal of nuclear medicine and molecular imaging, 2017-12-07, Vol.45 (5), p.699-711
4.
F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study
by Quak, Elske
European journal of nuclear medicine and molecular imaging, 2017-12-22, Vol.45 (4), p.658-666
5.
Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients
by Lasnon, Charline
European journal of nuclear medicine and molecular imaging, 2013-04-06, Vol.40 (7), p.985-996
6.
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients
by Quak, Elske
European journal of nuclear medicine and molecular imaging, 2015-07-30, Vol.42 (13), p.2072-2082
7.
Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement
by de Boysson, Hubert
European journal of nuclear medicine and molecular imaging, 2017-07-24, Vol.44 (13), p.2274-2279
8.
Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
by Salomon, Thibault
European journal of nuclear medicine and molecular imaging, 2017-12-26, Vol.45 (6), p.941-950
9.
Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver ste...
by Aide, Nicolas
European journal of nuclear medicine and molecular imaging, 2018-07-14, Vol.45 (12), p.2233-2234
10.
Reply to: “All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting”
by Lasnon, Charline
European journal of nuclear medicine and molecular imaging, 2018-02-23, Vol.45 (5), p.878-881
11.
Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma
by Aide, Nicolas
European journal of nuclear medicine and molecular imaging, 2018-02-17, Vol.45 (5), p.677-679
12.
Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community
by Aide, Nicolas
European journal of nuclear medicine and molecular imaging, 2017-05-24, Vol.44 (Suppl 1), p.1-3
13.
Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma
by Aide, Nicolas
European journal of nuclear medicine and molecular imaging, 2017-12-29, Vol.45 (4), p.675-675
14.
FDG PET-CT as a powerful tool for diagnosing and monitoring treatment outcomes of relapsing polychondritis
by Baudart, Pauline
European journal of nuclear medicine and molecular imaging, 2017-12-12, Vol.45 (4), p.669-670
15.
Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction
by Lasnon, Charline
Annals of nuclear medicine, 2016-11-03, Vol.31 (2), p.125-134
16.
Atypical gouty mediastinal tophus mimicking thymoma on 18F-FDG PET/CT
by Prigent, Kevin
European journal of nuclear medicine and molecular imaging, 2019-08-15, Vol.46 (12), p.2623-2624
17.
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
by Houdu, Benjamin
European journal of nuclear medicine and molecular imaging, 2018-09-14, Vol.46 (2), p.421-428
18.
FDG PET/CT for assessing tumour response to immunotherapy
by Nicolas Aide
European journal of nuclear medicine and molecular imaging, 2019-01-01, Vol.46 (1), p.238-250
19.
Revisiting detection of in-transit metastases in melanoma patients using digital 18F-FDG PET/CT with small-voxel reconstruction
by Zimmermann, Pierre-André
Annals of nuclear medicine, 2021-03-26, Vol.35 (6), p.669-679
20.
Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
by Bellevre, Dimitri
European journal of nuclear medicine and molecular imaging, 2014-02-22, Vol.41 (6), p.1103-1112
